Today, Boolzi will participate in the 3rd Meeting of the University Spin Off Network, at Universidad Nacional de San Martín.
Boolzi
Investigación biotecnológica
La Plata, Buenos Aires 294 seguidores
Boolzi provides cheminformatics services to the pharmaceutical sector.
Sobre nosotros
Boolzi provides B2B AI services to the pharmaceutical sector. Our solution is based on the hybridization of in-house machine learning and human expertise to reorient the development of shelved molecules for new therapeutic indications, biomarker identificaiton and AI-assisted clinical trial design.
- Sector
- Investigación biotecnológica
- Tamaño de la empresa
- De 2 a 10 empleados
- Sede
- La Plata, Buenos Aires
- Tipo
- Asociación
- Fundación
- 2023
Ubicaciones
-
Principal
Cómo llegar
La Plata, Buenos Aires 1900, AR
Empleados en Boolzi
-
Alan Talevi
Principal Researcher @ CONICET | Drug Design and Discovery
-
Santiago A. Sena
Ayudo a personas y organizaciones a prosperar, promoviendo mejores estilos de liderazgo y culturas
-
Luis Miguel Aras Portilla
Rare and Complex Epilepsies. Dravet Syndrome
-
Lucas Nicolas Alberca
PhD, Assistant Researcher CONICET
Actualizaciones
-
We are honoured to be among the 12 finalists chosen by The Ventures Argentina. Congratulations to the other 11 innovative startups that will be pitching this Friday. Minerva UNLP
📣 Congratulations to the finalists of The Ventures Argentina! We are thrilled to announce the 12 outstanding startups that have made it to the final round and are invited to pitch on November 15. These teams bring innovative solutions across various industries, and we can’t wait to see their presentations! Our finalists: Quix, elcerokm, Blockbites.ai, Boolzi, Unibaio, Prometheus Robotics, Houshares, MesencHyal-T, Recy, Bianca, Slice Token, ToshBank Wishing everyone the best of luck and inspiration on the path to victory! #TheVentures #Award #Argentina #Finalists #Innovation #PitchDay #Startups #FinalPitch
-
-
Boolzi 🤝🏼 ApoyoDravet 🦋 ✨We are proud to announce our partnership with ApoyoDravet. This collaboration focuses on the development of specific drugs for this genetic disease, based on the latest progress in understanding the molecular bases of Dravet syndrome and innovative modes of action for potential new therapies. Dravet syndrome is a rare, genetic form of epilepsy that causes prolonged, drug-resistant seizures starting before 15 months of age, developmental delays, and other health problems. Alan Talevi Santiago A. Sena Carolina Bellera Lucas Nicolas Alberca Luis Miguel Aras Portilla Minerva UNLP #DravetSyndrome #RareEpilepsy #Partnership #DrugDiscovery #Artificialintelligence
-
-
Boolzi | AI-based drug and biomarker solutions 💻💊🧬🦠 ➡We are an AI company focused on optimizing the drug discovery and development cycle to help more medications reach patients at lower costs. ↪Boolzi provides B2B AI and cheminformatics services to pharmaceutical companies and biomedical organizations. Our solution is based on the hybridization of in-house machine-learning tools and human expertise to reorient the development of shelved molecules for new therapeutic indications. Boolzi also provides AI assistance in the identification of complex biomarkers to maximize the chances of success in clinical trials. 🚀 The team: Alan Talevi Santiago A. Sena Carolina Bellera Lucas Nicolas Alberca 🙌 They support us: Luis Miguel Aras Portilla Rosana Felice Augusto PICH OTERO (PhD - MBA - Biochemist - Pharmacist) Minerva UNLP Universidad Nacional de La Plata Dirección de Vinculación Tecnologica de la Facultad de Cs. Exactas UNLP Juan Pedro B. #DrugDiscovery #PharmaTech #ArtificialIntelligence #Cheminformatics #CADD #AIDD #BiomarkerIdentification #ClinicalTrialsDesign #InSilicoDrugDiscovery #ADMEprediction
-
Working together 🤝 🥑 We are Palta
Presenting the new brand identity for Boolzi!👀 Boolzi is revolutionizing the pharmaceutical sector by tackling a critical issue: the many molecules that fail to make it to market⚛️. Only one in 10,000 investigated molecules becomes a new medicine. Boolzi aims to rescue and utilize the remaining 9,999 molecules to improve the success rate of clinical trials. We captured Boolzi's💊 innovative spirit and dedication to turning pharmaceutical investments into tangible results when crafting their brand. The logo and color palette embodies precision and uniqueness, perfectly encapsulating Boolzi's vision of a more efficient and thriving pharmaceutical industry🧪. At We are Palta🥑, we're proud to collaborate with visionary companies like Boolzi, driving change and pushing what's possible in biotech. 🚀 #AmplifyYourImpact #InPaltaWeTrust #Biotech
-
Boolzi ha compartido esto
I am honored to participate as a keynote speaker at the 9th Argentine Symposium of Young Researchers in Bioinformatics (5-6 Nov 2024), organized by ISCB SC RSG Argentina I will be talking about the use of supervised and unsupervised machine learning in the identification of bioactive scaffolds. LIDeB Boolzi https://lnkd.in/d7KNJ_4v